Repaglinide

Repaglinide

Cat Number
API135062021
CAS Number
135062-02-1

For research use only. We do not supply to patients.

For pharmaceutical-grade products or other inquiries, please contact our experts.

CAS Number
135062-02-1
EINECS
629-921-1
Storage
Store at room temperature
Synonyms
Prandin; GlucoNorm; Repaglinida; AG-EE 623 ZW; AG-EE 388 ZW; Repaglinidum; enyglid; DTXSID3023552
Molecular Formula
C27H36N2O4
Molecular Weight
452.6
Smiles
CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
Appearance
White to off-white powder
Melting Point
129-130.2°C
Boiling Point
672.9±55.0°C (Predicted)
Relative Density
1.137±0.06 (Predicted)
General Description
Repaglinide is a meglitinide derivative with a carbamoylbenzoic acid core and a piperidine ring, structurally distinct from sulfonylureas. Its chemical structure is (S)-2-ethoxy-4-[2-(3-methyl-1-[2-(piperidin-1-yl)phenyl]butylamino)-2-oxoethyl]benzoic acid.
Mechanism of Action
Repaglinide stimulates insulin secretion from the pancreatic beta cells by binding to the ATP-sensitive potassium channels (K-ATP) on the cell membrane, specifically the SUR1 subunit. This binding causes channel closure, membrane depolarization, and calcium influx, triggering the exocytosis of insulin-containing granules. The drug has a rapid onset and short duration of action, mimicking the physiological first-phase insulin release.
Application
Repaglinide is indicated as an adjunct to diet and exercise for the treatment of type 2 diabetes mellitus. It is effective in lowering postprandial glucose levels and is particularly useful in patients with irregular meal schedules. The drug is metabolized by CYP2C8 and CYP3A4 and is generally used in combination with metformin or other agents.

In 60 Chinese patients with newly diagnosed diabetes (HbA1c <10%), repaglinide and metformin similarly improved glycemic parameters and variability over 15 weeks. Repaglinide improved first-phase insulin secretion more markedly. In MIN-6 cells, repaglinide reduced insulin, pericentrin, and F-actin expression at 15 min, with sustained insulin secretion. The PCNT-F-actin pathway mediates repaglinide’s on-demand insulin secretion.

Fig. 1 Intravenous glucose tolerance tests (IVGTTs) 0 to 10 minutes curves and area under curves (AUCs) for the repaglinide group and the metformin group. (Wang LC, <i>et al</i>., 2018) Fig. 1 Intravenous glucose tolerance tests (IVGTTs) 0 to 10 minutes curves and area under curves (AUCs) for the repaglinide group and the metformin group. (Wang LC, et al., 2018)

References

  1. Wang LC, et al. Characteristics of repaglinide and its mechanism of action on insulin secretion in patients with newly diagnosed type-2 diabetes mellitus. Medicine (Baltimore). 2018;97(38):e12476.

In chronic unpredicted mild stress (CUMS)‑induced depression in GK rats, repaglinide pharmacokinetics were significantly altered, with increased plasma cortisol and epinephrine. Liver gene expression profiling identified 49 differentially expressed genes enriched in drug metabolism and steroid hormone pathways. CAR and Ugt1a1 protein expression increased. Dexamethasone and 8‑Br‑cAMP upregulated Ugt1a1, Nr1i2, and PXR in BRL 3A cells. Depression upregulates DMEs via glucocorticoid signaling.

Fig. 2 The network of up-regulated differentially expressed genes in liver tissue of GK rats. (Wei H, <i>et al</i>., 2017) Fig. 2 The network of up-regulated differentially expressed genes in liver tissue of GK rats. (Wei H, et al., 2017)

References

  1. Wei H, et al. Impact of chronic unpredicted mild stress-induced depression on repaglinide fate via glucocorticoid signaling pathway. Oncotarget. 2017;8(27):44351-44365.

Does Repaglinide require protection from light during long-term storage?

Yes, it is photosensitive. UV exposure can cause photodegradation and discoloration. Store in light-resistant containers, preferably amber glass.

What is the recommended storage temperature for Repaglinide?

Store at controlled room temperature (15-25°C). Avoid excessive heat above 30°C, which can soften the powder and accelerate oxidative degradation.

Is Repaglinide stable in tablet formulations with standard excipients?

Yes, when formulated with moisture-protective packaging.

How is the impurity repaglinide N-oxide (an oxidative degradation product) monitored?

This degradation product is quantified using a stability-indicating HPLC method, ensuring it remains within ICH qualification thresholds.
You Might Also Like
R-Lipoic Acid
R-Lipoic Acid

Cat NO.: API1200222
CAS NO.: 1200-22-2

View Details
Mazdutide
Mazdutide

Cat NO.: API2259884030
CAS NO.: 2259884-03-0

View Details
Ertugliflozin
Ertugliflozin

Cat NO.: API1210344572
CAS NO.: 1210344-57-2

View Details
Linagliptin
Linagliptin

Cat NO.: API668270120
CAS NO.: 668270-12-0

View Details
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Contact Us
USA

Tel:
Email:
Address:

 
Denmark

Tel:
Email:
Address:

WhatsAPP
WhatsAPP (Sales #1)
WhatsAPP
WhatsAPP (Sales #2)
WhatsAPP
WhatsAPP (Sales #3)

All our products are chemicals for research purposes only. We do not supply for human or veterinary applications.

Privacy Policy | Cookie Policy Copyright © Protheragen. All Rights Reserved.


WhatsAPP
Top